Maryland Senate Bill SB506

Maryland 2026 Regular Session

• Introduced: 2/2/26
• Refer: 2/2/26

Caption

Health Occupations - Pharmacists - Minor Conditions and HIV Prevention and Treatment

Impact

The proposed bill has significant implications for state laws governing healthcare and the role of pharmacists. By repealing existing provisions related to the Nonoccupational Postexposure Prophylaxis (nPEP) Standing Order Program, SB506 allows for a broader interpretation of what pharmacists can do in terms of public health interventions. It empowers pharmacists to take a more proactive role in managing minor health conditions, thus enhancing patient access to necessary treatments without needing a physician's immediate involvement. This has the potential to ease the burden on the healthcare system by providing patients with timely access to care.

Summary

Senate Bill 506, titled 'Health Occupations – Pharmacists – Minor Conditions and HIV Prevention and Treatment', seeks to expand the scope of practice for pharmacists in Maryland. The bill authorizes pharmacists to prescribe, administer, and dispense certain medications or devices related to minor health conditions and human immunodeficiency virus (HIV) prevention and treatment. Importantly, it includes the establishment of statewide written protocols for these practices, allowing pharmacists to perform laboratory tests as guided by approved protocols. This legislative change aims to increase access to healthcare services, particularly in underserved areas.

Contention

Despite its positive potential, the bill has faced some contention. Some stakeholders worry that expanding pharmacists' authority without adequate supervision or training could lead to inconsistencies in care and possible mismanagement of more serious health conditions. Supporters argue that pharmacists are highly trained professionals who can effectively handle these responsibilities, but opponents raise concerns regarding the adequacy of oversight and the potential for overstepping professional boundaries. The discussions around SB506 reflect a broader debate on the role of pharmacists in health care and the balance between expanding their authority and ensuring safe practices.